Serum chemokine profiles in patients with alopecia areata. 2007

Y Kuwano, and M Fujimoto, and R Watanabe, and N Ishiura, and H Nakashima, and Y Ohno, and S Yano, and N Yazawa, and H Okochi, and K Tamaki
Department of Dermatology, Faculty of Medicine, University of Tokyo, Tokyo, Japan.

BACKGROUND Although chemokines play an important role in various inflammatory diseases, there have been few studies about the role of chemokines in alopecia areata (AA). OBJECTIVE To determine serum levels of chemokines in patients with AA and their clinical correlations. METHODS Serum samples from 85 patients with AA, 20 patients with atopic dermatitis, 20 patients with psoriasis vulgaris and 28 normal controls were examined by the cytometric bead array assay assessing monokine induced by interferon (IFN)-gamma (MIG), RANTES, interleukin-8 (IL-8), IFN-inducible protein-10, monocyte chemoattractant protein-1, macrophage inflammatory protein (MIP)-1alpha, MIP-1beta and eotaxin levels. Secreted chemokine levels from peripheral blood mononuclear cells (PBMC) of patients with AA were also investigated. RESULTS Serum MIG, RANTES, IL-8 and eotaxin levels were selectively increased in patients with AA compared with normal controls. Levels of MIG, RANTES and IL-8 secreted from PBMC of patients with AA were also increased. Furthermore, elevated serum MIG and RANTES levels significantly correlated with the disease activity. RANTES levels were nonsignificantly associated with a predisposition to atopy. CONCLUSIONS These results suggest that MIG and RANTES play an important role in the development of AA and are useful as markers of disease activity and as therapeutic targets.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D003876 Dermatitis, Atopic A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema. Eczema, Atopic,Eczema, Infantile,Neurodermatitis, Atopic,Neurodermatitis, Disseminated,Atopic Dermatitis,Atopic Eczema,Atopic Neurodermatitis,Disseminated Neurodermatitis,Infantile Eczema
D004198 Disease Susceptibility A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases. Diathesis,Susceptibility, Disease,Diatheses,Disease Susceptibilities,Susceptibilities, Disease
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Y Kuwano, and M Fujimoto, and R Watanabe, and N Ishiura, and H Nakashima, and Y Ohno, and S Yano, and N Yazawa, and H Okochi, and K Tamaki
January 2016, The Journal of dermatological treatment,
Y Kuwano, and M Fujimoto, and R Watanabe, and N Ishiura, and H Nakashima, and Y Ohno, and S Yano, and N Yazawa, and H Okochi, and K Tamaki
January 2016, Indian dermatology online journal,
Y Kuwano, and M Fujimoto, and R Watanabe, and N Ishiura, and H Nakashima, and Y Ohno, and S Yano, and N Yazawa, and H Okochi, and K Tamaki
October 2023, Acta dermato-venereologica,
Y Kuwano, and M Fujimoto, and R Watanabe, and N Ishiura, and H Nakashima, and Y Ohno, and S Yano, and N Yazawa, and H Okochi, and K Tamaki
February 1984, The British journal of dermatology,
Y Kuwano, and M Fujimoto, and R Watanabe, and N Ishiura, and H Nakashima, and Y Ohno, and S Yano, and N Yazawa, and H Okochi, and K Tamaki
November 2008, Journal of the European Academy of Dermatology and Venereology : JEADV,
Y Kuwano, and M Fujimoto, and R Watanabe, and N Ishiura, and H Nakashima, and Y Ohno, and S Yano, and N Yazawa, and H Okochi, and K Tamaki
April 2014, Indian dermatology online journal,
Y Kuwano, and M Fujimoto, and R Watanabe, and N Ishiura, and H Nakashima, and Y Ohno, and S Yano, and N Yazawa, and H Okochi, and K Tamaki
January 2019, Indian journal of dermatology, venereology and leprology,
Y Kuwano, and M Fujimoto, and R Watanabe, and N Ishiura, and H Nakashima, and Y Ohno, and S Yano, and N Yazawa, and H Okochi, and K Tamaki
April 2019, Journal of Nepal Health Research Council,
Y Kuwano, and M Fujimoto, and R Watanabe, and N Ishiura, and H Nakashima, and Y Ohno, and S Yano, and N Yazawa, and H Okochi, and K Tamaki
April 2017, Journal of the American Academy of Dermatology,
Y Kuwano, and M Fujimoto, and R Watanabe, and N Ishiura, and H Nakashima, and Y Ohno, and S Yano, and N Yazawa, and H Okochi, and K Tamaki
November 2013, The Journal of dermatology,
Copied contents to your clipboard!